Carrying on their father’s legacy: Siblings team up to take on LOWVELO
The Perlmutters rode in LOWVELO25 to honor their father, Marty, and give back to the community that supported him through treatment. In fact, LOWVELO riders helped to fund a CAR-T clinical trial at MUSC Hollings Cancer Center that builds upon the success of the CAR-T treatment their father received. That’s why it was second nature for his children to join the LOWVELO family – riding in his honor and helping to fund the cures of tomorrow.
Inspiring action: Overture Daniel Island resident rallies community to raise awareness and funds for LOWVELO
Despite her lack of expertise in cycling, two-time cancer survivor, Joannah Sampson, has helped to raise nearly $12,000 for LOWVELO in the past two years. Her team, Overture Daniel Island, was created in 2024 to inspire residents of the active-living community with the same name to participate in LOWVELO and raise funds for lifesaving cancer research at MUSC Hollings Cancer Center.
Momentum Builds: LOWVELO hits record $1.13 million for cancer research
Another million-dollar moment set up another record-breaking year for LOWVELO. Riders in LOWELO25 teamed up to raise more money for lifesaving cancer research at MUSC Hollings Cancer Center than any ride in its seven-year history. It all culminated Wednesday night with the Jerry Zucker Awards Ceremony at the Cooper River Room in Mount Pleasant.
A second chance: LOWVELO rider living with leukemia bringing hope to the Charleston area, one bike at a time
A bicycle – it was a practical gift that ended up being the catalyst for her whole lifestyle and got her through a cancer diagnosis. Now, Sylvie Baele wants to help others use bikes to improve their lives. It’s why she runs Charleston’s only nonprofit bike shop and why she rides in LOWVELO.
Where the money goes: Developing novel treatments to help patients quit tobacco products
Amanda Palmer, Ph.D.’s goal as a researcher is to develop and test treatments for quitting new tobacco products, like e-cigarettes. Thanks to LOWVELO rider-raised funds her research is providing a roadmap of what health effects should be looked at in treatment studies. This helps Palmer find the best ways to help people stop using tobacco and learn more about how their bodies benefit from quitting.
Get ready for LOWVELO25 Glow Blue Week!
LOWVELO Glow Blue Week is Sept. 22-25! Join us as we light up MUSC Hollings Cancer Center in blue for LOWVELO25! This week-long pep rally includes special events, free registration for our Nov. 1 ride and fun giveaways all week long. Learn more about eh exciting events happening each day. See you there!
LOWVELO sponsor riding for the future of cancer research, legacy of his father
LOWVELO sponsor Brent Tabor has a very personal tie to the ride. His dad, Ed, battled lymphoma for more than a decade. He even tried what he referred to as his “Hail Mary pass” – an immunotherapy called CAR-T cell therapy. It’s a treatment that could be game-changing for cancer. Now Brent rides to honor his father’s legacy and to further the future of cancer research.
LOWVELO is for everyone: Hollings researcher and artist finds creative way to fundraise
The ways to get involved in LOWVELO are limitless, and Hollings researcher Nancy Klauber DeMore, M.D., is the perfect example of how anyone can join. Her art collection, “Blooming Expressions: A Dance of Color” is currently being featured at the Charleston Artist Guild Gallery, and she is donating a portion of all sales during the month of May to LOWVELO.
LOWVELO funding allows Hollings Cancer Center researchers to study depression in cancer survivors
Data shows that one in four cancer survivors suffers from depression, which can lead to decreased physical and social functioning, a lower quality of life and reduced survival rates. This is why a team of MUSC Hollings Cancer Center researchers, with funding from LOWVELO, is working to reduce depression among a growing population of survivors and improve their quality of life.
Where the money goes: researcher using LOWVELO funds to revolutionize treatment for solid tumors
Most people don’t have a positive reaction to seeing blood. But MUSC Hollings Cancer Center researcher Leonardo Ferreira, Ph.D. isn’t most people. “Every time I look at a drop of blood, I see cells screaming to be weaponized against cancer.” Ferreira’s lab hopes to bring CAR-T cell therapy, a game-changing treatment showing success in liquid tumors to solid tumors.